Bill & Melinda Gates Foundation logo

Bill & Melinda Gates Foundation

North America, New York, United States, New York

Description

The Bill & Melinda Gates Foundation stands as one of the world's preeminent philanthropic organizations, established by Bill and Melinda Gates with a profound commitment to reducing inequity and improving lives globally. Unlike traditional venture capital firms, the Foundation operates primarily as a grant-making entity, channeling its vast resources towards addressing critical challenges in global health, poverty, and education. Its strategic approach is rooted in fostering innovation and delivering measurable impact, rather than seeking financial returns on its "investments."

With an endowment that has exceeded $50 billion, the Foundation possesses unparalleled financial capacity to fund ambitious initiatives worldwide. Since its inception, it has disbursed over $70 billion in grants, making it a monumental force in global development and humanitarian efforts. These funds are primarily directed towards non-profit organizations, research institutions, and, occasionally, for-profit entities whose work directly aligns with the Foundation's charitable objectives. Funding mechanisms include direct grants, as well as Program-Related Investments (PRIs), which are financial tools designed to achieve specific programmatic goals with a social return focus.

The Foundation's funding strategy is highly data-driven and outcomes-oriented, focusing on scalable solutions to complex global problems. It supports a diverse portfolio of initiatives, ranging from the development and distribution of vaccines to eradicate diseases like polio and malaria, to advancing agricultural productivity in developing nations, and improving educational outcomes. Their "investments" are characterized by a long-term perspective, aiming to create sustainable systemic change rather than short-term fixes.

While the Foundation does not issue "cheques" in the conventional venture capital sense, its funding amounts vary significantly based on the scope and nature of the project. Individual grants can range from approximately $50,000 for focused research projects or smaller-scale community initiatives, extending up to hundreds of millions of dollars for large-scale global health programs or multi-year commitments to major international organizations. This broad range reflects their commitment to supporting both foundational research and widespread implementation efforts across their core focus areas.

Investor Profile

Bill & Melinda Gates Foundation has backed more than 343 startups, with 43 new investments in the last 12 months alone. The firm has led 250 rounds, about 73% of its total and boasts 66 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 40 rounds in the past year.
  • Typical check size: $50K – $100M.

Stage Focus

  • Grant (77%)
  • Series A (6%)
  • Series B (4%)
  • Series Unknown (4%)
  • Series C (3%)
  • Seed (3%)
  • Series E (1%)
  • Series D (1%)
  • Debt Financing (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (54%)
  • United Kingdom (9%)
  • Canada (4%)
  • India (4%)
  • Germany (4%)
  • Kenya (3%)
  • The Netherlands (3%)
  • Switzerland (2%)
  • China (1%)
  • Nigeria (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biopharma
  • Education
  • Medical Device
  • Life Science
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bill & Melinda Gates Foundation frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Nomura
Asia, Tokyo, Japan, Tokyo
Co-Investments: 4
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 7
Lux Capital
North America, New York, United States, New York
Co-Investments: 4
Oikocredit International
Europe, Utrecht, The Netherlands, Amersfoort
Co-Investments: 4
Omidyar Network
North America, California, United States, Redwood City
Co-Investments: 4
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 7

Which angels does Bill & Melinda Gates Foundation often collaborate with?

LW
North America, Washington, United States, Seattle
Shared Deals: 1
Pratul Shroff
Asia, Gujarat, India, Ahmedabad
Shared Deals: 2
JR
North America, California, United States, San Francisco
Shared Deals: 2
TG
Asia, United Arab Emirates
Shared Deals: 1
VB
Europe, England, United Kingdom, London
Shared Deals: 1
EB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Bill & Melinda Gates Foundation?

Tessera Therapeutics

Cambridge, Massachusetts, United States

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

BiopharmaBiotechnologyGeneticsLife ScienceTherapeutics
GrantMar 23, 2026
Rainbow Crops

Gent, Oost-Vlaanderen, Belgium

Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.

AgricultureAgTechArtificial Intelligence (AI)
GrantMar 4, 2026
Amount Raised: $7,000,000
Plasmaleap

Sydney, New South Wales, Australia

Plasmaleap is a plasma technology company that manufactures and sells advanced zero-emissions chemical reactors for various sectors.

IndustrialIndustrial ManufacturingManufacturing
Series AMar 2, 2026
Amount Raised: $21,297,228
Ten63 Therapeutics

Durham, North Carolina, United States

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.

BiotechnologyHealth CareMedicalPharmaceutical
GrantFeb 19, 2026
Ten63 Therapeutics

Durham, North Carolina, United States

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownFeb 19, 2026
Axmed

Basel, Basel-Stadt, Switzerland

Axmed is a medical marketplace that offers access to medicines for healthcare providers through business and technology solutions.

Health CareMarketplaceMedicalTherapeutics
GrantFeb 17, 2026
Amount Raised: $6,000,000
Centivax

South San Francisco, California, United States

Centivax is a biotechnology company that develops vaccines and therapeutic antibodies targeting infectious diseases and venomous threats.

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics
GrantFeb 12, 2026
Amount Raised: $26,000,000
Carnegie Mellon University

Pittsburgh, Pennsylvania, United States

Carnegie Mellon University is a research university offering programs and research across engineering, science, arts, and business.

EducationHigher EducationUniversities
GrantJan 29, 2026
Amount Raised: $55,000,000
Heritable Agriculture

Mountain View, California, United States

Heritable Agriculture focuses on improving plant breeding and biotechnology to strengthen the world's food and agricultural systems.

Agriculture
GrantJan 28, 2026
Amount Raised: $4,980,000
Qure AI

Andheri, Maharashtra, India

Qure AI is a healthcare technology company that provides automated interpretation of radiology exams and ultrasounds scans.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedical Device
GrantJan 22, 2026
Amount Raised: $8,000,000

Find More Investors Like Bill & Melinda Gates Foundation

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Bill & Melinda Gates Foundation | Pipeseed